C4 Therapeutics, Inc. (CCCC) Capital expenditures 2019–2025
C4 Therapeutics, Inc. (CCCC) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
$607,000FY2025 · since FY2019: $1.3M → $607,000
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $607,000 | +237.2% |
| FY2024 | $180,000 | -89.5% |
| FY2023 | $1.7M | -68.9% |
| FY2022 | $5.5M | +330.4% |
| FY2021 | $1.3M | +96.5% |
| FY2020 | $650,000 | -51.8% |
| FY2019 | $1.3M | — |
Capital expenditures are shown as the positive cash amount spent, as reported on the cash-flow statement.
Source: SEC XBRL filings · For reference only · Not investment advice